Table 4 Spearman correlations between the EQ-5D and the MMSE and between the EQ-5D+C and the MMSE at baseline, six months and 12 months (construct validity)
From: Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
N = 196 | Baseline | 6 months | 12 months |
|---|---|---|---|
EQ-5D: | |||
Utility score | 0.19** | 0.45** | 0.50** |
Mobility | -0.02 | -0.17* | -0.23** |
Self-Care | -0.28** | -0.50** | -0.55** |
Usual activities | -0.34** | -0.42** | -0.52** |
Pain/Discomfort | -0.01 | -0.14* | -0.05 |
Anxiety/Depression | -0.05 | -0.17* | -0.22** |
VAS5D | 0.22** | 0.23** | 0.23** |
EQ-5D+C: | |||
Cognition | -0.35** | -0.52** | -0.54** |
VAS5D+C | 0.37** | 0.47** | 0.48** |